发明名称 IgE antibodies for the inhibition of tumor metastasis
摘要 The present invention provides novel IgE antibodies useful for inhibiting or preventing metastatic cancer. Also provided are methods to inhibit tumor metastasis by modulating the activity of at least one non-tumor cell, treating a patient to inhibit or prevent tumor metastases of a primary solid tumor, treating metastatic carcinoma, reducing metastasis of carcinoma cells, and reducing the growth kinetics of a primary solid tumor or a metastasized cell or tumor.
申请公布号 US9587032(B2) 申请公布日期 2017.03.07
申请号 US201313939781 申请日期 2013.07.11
申请人 The Board of Trustees of the Leland Stanford Junior University 发明人 Mollick Joseph A.;Teo Pearline;Utz Paul J.
分类号 C07K16/28;C07K16/30;A61K39/00 主分类号 C07K16/28
代理机构 Kilpatrick Townsend & Stockton LLP 代理人 Kilpatrick Townsend & Stockton LLP
主权项 1. An IgE monoclonal antibody that specifically binds an epitope of MUC1 and is capable of modulating immune effector cells to inhibit tumor metastasis having a heavy chain variable region encoded by a nucleic acid comprising CDRs 1-3 of a heavy chain variable region encoded by SEQ ID NO: 1 and a light chain variable region encoded by a nucleic acid comprising CDRs 1-3 of a light chain variable region encoded by SEQ ID NO: 2, optionally humanized.
地址 Palo Alto CA US